TY - JOUR T1 - Negative vaccine attitudes and intentions to vaccinate against Covid-19 in relation to smoking status: a population survey of UK adults JF - medRxiv DO - 10.1101/2020.12.17.20248396 SP - 2020.12.17.20248396 AU - Sarah E. Jackson AU - Elise Paul AU - Jamie Brown AU - Andrew Steptoe AU - Daisy Fancourt Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/12/19/2020.12.17.20248396.abstract N2 - Introduction We examined differences in negative attitudes towards vaccines in general, and intentions to vaccinate against Covid-19 specifically, by smoking status in a large sample of adults in the UK.Method Data were from 29,148 adults participating in the Covid-19 Social Study in September-October 2020. Linear regression analyses examined associations between smoking status (current/former/never) and four types of general negative vaccine attitudes: mistrust of vaccine benefit, worries about unforeseen effects, concerns about commercial profiteering, and preference for natural immunity. Multinomial logistic regression examined associations between smoking status and uncertainty and unwillingness to be vaccinated for Covid-19. Covariates included sociodemographic characteristics and diagnosed health conditions.Results Relative to never and former smokers, current smokers reported significantly greater mistrust of vaccine benefit, were more worried about unforeseen future effects, had greater concerns about commercial profiteering, and had a stronger preference for natural immunity (Badjs 0.16-0.36, p<0.001). Current smokers were more likely to be uncertain (27.6% vs. 22.7% of never smokers: RRadj 1.43 [95%CI 1.31-1.56]; vs. 19.3% of former smokers: RRadj 1.55 [1.41-1.73]) or unwilling (21.5% vs. 11.6% of never smokers: RRadj 2.12 [1.91-2.34]; vs. 14.7% of former smokers: RRadj 1.53 [1.37-1.71]) to receive a Covid-19 vaccine.Conclusions Current smokers hold more negative attitudes towards vaccines in general, and are more likely to be undecided or unwilling to vaccinate against Covid-19, compared with never and former smokers. With a disproportionately high number of smokers belonging to socially clustered and disadvantaged socioeconomic groups, lower vaccine uptake in this group could also exacerbate health inequalities.Implications These results suggest that without intervention, smokers will be less likely than non-smokers to take up the offer of a Covid-19 vaccine when offered. Targeted policy action may be required to ensure low uptake of Covid-19 vaccination programmes does not compound health inequalities between smokers and non-smokers.Competing Interest StatementJB has received unrestricted research funding from Pfizer, who manufacture smoking cessation medications. All authors declare no financial links with tobacco companies or e-cigarette manufacturers or their representatives.Funding StatementThe Covid-19 Social Study is supported by the Nuffield Foundation [WEL/FR-000022583], the MARCH Mental Health Network funded by the Cross-Disciplinary Mental Health Network Plus initiative supported by UK Research and Innovation [ES/S002588/1], and the Wellcome Trust [221400/Z/20/Z and 205407/Z/16/Z]. SJs salary is supported by Cancer Research UK (C1417/A22962). The funders had no final role in the study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication. All researchers listed as authors are independent from the funders and all final decisions about the research were taken by the investigators and were unrestricted.  Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval for the COVID-19 Social Study was granted by the UCL Ethics Committee [12467/005]. All participants provided fully informed consent and the study is GDPR compliant.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe COVID-19 Social Study documentation and codebook are available for download at https://www.covidsocialstudy.org/. ER -